NCT06342687View on ClinicalTrials.gov

Compliance With ERAS and Five Year Survival After Colorectal Cancer Treatment

CompletedOBSERVATIONAL
Enrollment

468

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Colorectal CancerERAS
Interventions
PROCEDURE

High compliance with ERAS protocol

Patients were categorized into two groups based on their adherence to the ERAS protocol: group 1 with a compliance rate below 80% and group 2 with a compliance rate of 80% or above.

Trial Locations (1)

31-008

Jagiellonian University Medical College, Krakow

All Listed Sponsors
lead

Jagiellonian University

OTHER

NCT06342687 - Compliance With ERAS and Five Year Survival After Colorectal Cancer Treatment | Biotech Hunter | Biotech Hunter